ESMO Real World Data and Digital Oncology is a peer-reviewed english-language open-access journal published by Elsevier in United Kingdom, operating under an open-access model since 2023. The journal covers Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Authors are required to pay an article processing charge to publish in ESMO Real World Data and Digital Oncology; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY-NC-ND license (see other journals using this license).
To date, ESMO Real World Data and Digital Oncology has published 576 articles. Articles are minted with DOIs through the prefix 10.1016. All submissions undergo plagiarism screening before peer review.
Keywords
clinical informatics solutions, algorithm-powered diagnostics, decision support systems, direct-to-patient mobile applications, oncology, cancer
At a glance
- Publisher
- Elsevier
- Country
- United Kingdom
- Primary language
- English
- License
- CC BY-NC-ND
- Peer review
- Anonymous peer review
- OA since
- 2023
- Review time
- 20 weeks
- DOI prefix
10.1016- Plagiarism check
- Yes
ISSN
- electronic
- 2949-8201
Frequently asked questions
Is ESMO Real World Data and Digital Oncology peer-reviewed?
Does ESMO Real World Data and Digital Oncology charge an article processing charge (APC)?
What subjects does ESMO Real World Data and Digital Oncology publish?
What languages does ESMO Real World Data and Digital Oncology accept?
What is the ISSN of ESMO Real World Data and Digital Oncology?
2949-8201 (electronic).